Calculation of Platelet-rich Plasma Preparation Yield

August 8, 2017 updated by: Theodore Harrison, MD, Harrison, Theodore, M.D.

Calculation of Platelet-rich Plasma Preparation Yield From Baseline CBC Platelet Count

This is a study to determine 1) the consistency of platelet-rich plasma produced by several methods, and 2) whether the platelet content of platelet-rich plasma can be accurately estimated from a baseline CBC platelet count.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

In the first phase of this study a baseline CBC platelet count will be performed on each subject and then platelet-rich plasma (PRP) prepared from the same blood sample by six different methods. The platelet count will be measured in each PRP preparation and compared to the CBC platelet count to determine the platelet yield for each method.

In the second phase of the study a baseline CBC platelet count will be performed on each subject and then platelet-rich plasma (PRP) prepared from the same blood sample by six different methods. The CBC platelet count will be used to calculate the estimated platelet content of each sample/method based on the platelet yields determined in the first phase. The platelet count will be measured in each PRP preparation and compared to the estimated platelet content to determine the predictive accuracy for each method.

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Sidney, British Columbia, Canada, V8L5K1
        • Theodore E Harrison

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

normal adults

Description

Inclusion Criteria:

  • English speaking

Exclusion Criteria:

  • platelet count < 150,000
  • platelet count > 350,000
  • History of blood disorder
  • History of altered platelet function
  • History of chemotherapy or radiation therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Platelet yield
Time Frame: within 8 hours of blood draw
the number of platelets in a PRP sample as a percentage of the number of platelets in the blood from which the PRP was prepared.
within 8 hours of blood draw
Platelet yield estimate accuracy
Time Frame: within one month of final data collection
standard deviation of the difference between the estimated platelet yield and the actual platelet yield.
within one month of final data collection

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Theodore E Harrison, Theodore Harrison

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 30, 2017

Primary Completion (ANTICIPATED)

May 31, 2018

Study Completion (ANTICIPATED)

May 31, 2018

Study Registration Dates

First Submitted

May 18, 2017

First Submitted That Met QC Criteria

May 18, 2017

First Posted (ACTUAL)

May 22, 2017

Study Record Updates

Last Update Posted (ACTUAL)

August 10, 2017

Last Update Submitted That Met QC Criteria

August 8, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • PRP Platelet Yield

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Platelet-rich Plasma Production

Clinical Trials on venipuncture

3
Subscribe